Patent · US Active

Chemical compounds

US9616050B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2015
Grant dateApr 11, 2017
Priority date
Expiry dateAug 31, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention concerns compounds of Formula (I)or pharmaceutically-acceptable salts thereof, wherein R1 to R5 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.